Table 1 General characteristics of study group
Characteristics | Initial diagnosis with IMN involved(n = 34) | Recurrence with IMN involved (n = 36) | All patients (n = 70)* |
|---|---|---|---|
ER status, n(%) | |||
 Positive | 20 (58.8) | 25 (69.4) | 45 (64.3) |
 Negative | 12 (35.3) | 10 (27.8) | 22 (31.4) |
 Unknown | 2 (5.9) | 1 (2.8) | 3 (4.3) |
PR status, n(%) | |||
 Positive | 13 (38.2) | 19 (52.8) | 32 (45.7) |
 Negative | 18 (52.9) | 15 (41.7) | 33 (47.1) |
 Unknown | 3 (8.8) | 2 (5.6) | 5 (7.1) |
HER2 status, n(%) | |||
 Positive | 12 (35.3) | 11 (30.6) | 23 (32.9) |
 Negative | 20 (58.8) | 22 (61.1) | 42 (60.0) |
 Unknown | 2 (5.9) | 3 (8.3) | 5 (7.1) |
T stage, n(%) | |||
 Tis | 1 (2.9) | 0 (0) | 1 (1.4) |
 T1 | 4 (11.8) | 10 (27.8) | 14 (20.0) |
 T2 | 13 (38.2) | 17 (47.2) | 30 (42.9) |
 T3 | 4 (11.8) | 2 (5.6) | 6 (8.6) |
 T4 | 8 (23.5) | 1 (2.8) | 9 (12.9) |
 Tx | 4 (11.8) | 6 (16.7) | 10 (14.3) |
N stage, n(%) | |||
 N0 | 0 (0) | 19 (52.8) | 19 (27.1) |
 N1 | 0 (0) | 6 (16.7) | 6 (8.6) |
 N2 | 1 (2.9) | 3 (8.3) | 4 (5.7) |
 N3 | 33 (97.1) | 6 (16.7) | 39 (55.7) |
 Nx | 0 (0) | 2 (5.6) | 2 (2.9) |
M status, n(%) | |||
 M0 | 20 (58.8) | 15 (41.7) | 35 (50.0) |
 M1 | 14 (41.2) | 21 (58.3) | 35 (50.0) |